Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
R Clinical implications of slow acetylation: Increased risk of isoniazid-induced hepatotoxicity and peripheral neuropathy (tuberculosis treatment) R Increased risk of sulfonamide hypersensitivity reactions R Increased risk of aromatic amine-related bladder cancer in occupational exposure settings (dye workers, rubber industry) R Drug-induced lupus from hydralazine and procainamide occurs almost exclusively in slow acetylators R Altered caffeine metabolism (slow acetylators clear caffeine more slowly via the NAT2 pathway) R NAT1 polymorphisms are less well characterized but the slow allele NAT1*14 has been associated with increased risk of cancers from dietary aromatic amines
Reverse transcription and quantitative PCR Cells were seeded in six-well dishes and treated with desired reagents
The addition of 1.5 mM GSH resulted in a total of 81 vitrified oocytes, with 58 oocytes surviving (72.28.6)%, 7 with zona pellucida fractures (4.91.1)%, 7 with cytoplasmic shrinkage (12.33.8)%, and 7 with cytoplasmic lysis (10.63.7)% (Table 4)
Who can benefit from peptide therapy
Medicare spending on GLP-1s has surged, raising concerns about long-term affordability and access 2
